Pathfinder Cell Therapy, Inc. (PFND)
PFND Stock Price Chart
Explore Pathfinder Cell Therapy, Inc. interactive price chart. Choose custom timeframes to analyze PFND price movements and trends.
PFND Company Profile
Discover essential business fundamentals and corporate details for Pathfinder Cell Therapy, Inc. (PFND) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
3 Jan 2000
Employees
1.00
CEO
Richard L. Franklin
Description
Pathfinder Cell Therapy, Inc., a development stage regenerative medicine company, focuses on developing novel cell-derived and related therapies for the treatment of various diseases and medical conditions characterized by organ-specific cell damage. It identifies diabetes, renal disease, myocardial infarction, peripheral vascular disease, and other diseases as potential indications for therapies based on its technology. The company was founded in 2008 and is headquartered in Cambridge, Massachusetts.
PFND Financial Timeline
Browse a chronological timeline of Pathfinder Cell Therapy, Inc. corporate events including earnings releases, dividend announcements, and stock splits.
PFND Stock Performance
Access detailed PFND performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.